144 related articles for article (PubMed ID: 524352)
1. Effect of triamterene on urinary excretion of immunoreactive prostaglandin E in essential hypertension.
Chiba S; Abe K; Yasujima M; Irokawa N; Saito K; Sakurai Y; Ito T; Sato M; Otsuka Y; Yoshinaga K
Tohoku J Exp Med; 1979 Nov; 129(3):249-56. PubMed ID: 524352
[TBL] [Abstract][Full Text] [Related]
2. Renal kallikrein-kinin system and prostaglandin in hypertension: their relation to renin-angiotensin-aldosterone system.
Abe K; Yasujima M; Chiba S; Sato M; Irokawa N; Imai Y; Yoshinaga K
Adv Exp Med Biol; 1979; 120B():487-501. PubMed ID: 517244
[TBL] [Abstract][Full Text] [Related]
3. Effect of spironolactone on urinary excretion of immunoreactive prostaglandin E in essential hypertension and primary aldosteronism.
Chiba S; Abe K; Yasujima M; Irokawa N; Seino M; Sakurai Y; Sato M; Otsuka Y; Yoshinaga K
Tohoku J Exp Med; 1978 Apr; 124(4):297-305. PubMed ID: 663929
[TBL] [Abstract][Full Text] [Related]
4. Implication of renal prostaglandin E in urinary sodium excretion.
Yasujima M; Abe K; Chiba S; Sato M; Irokawa N; Seino M; Imai Y; Saito K; Sakurai Y; Ito T; Haruyama T; Ritsu K; Yoshinaga K
Jpn Circ J; 1978 May; 42(5):565-9. PubMed ID: 702774
[TBL] [Abstract][Full Text] [Related]
5. The role of renal prostaglandin E and kallikrein in pathogenesis of essential hypertension.
Abe K; Yasujima M; Sakurai Y; Chiba S; Itoh T; Imai Y; Sato M; Haruyama T; Omata K; Goto T; Sato K; Hiwatari M; Otsuka Y; Yoshinaga K
Jpn Circ J; 1979 Dec; 43(12):1105-16. PubMed ID: 396385
[No Abstract] [Full Text] [Related]
6. Spironolactone and triamterene in volume-dependent essential hypertension.
DeCarvalho JG; Emery AC; Frohlich ED
Clin Pharmacol Ther; 1980 Jan; 27(1):53-6. PubMed ID: 6985854
[TBL] [Abstract][Full Text] [Related]
7. Hypotensive and natriuretic effects of nifedipine in essential hypertension. Role of renal kallikrein-kinin-prostaglandin and renin-angiotensin-aldosterone systems.
Tsunoda K; Abe K; Omata K; Kudo K; Sato M; Kohzuki M; Tanno M; Seino M; Yasujima M; Yoshinaga K
J Clin Hypertens; 1986 Sep; 2(3):263-70. PubMed ID: 3640807
[TBL] [Abstract][Full Text] [Related]
8. Effect of propranolol on the urinary excretion of prostaglandin E and plasma renin activity in hypertensive patients.
Sato M; Abe K; Yasujima M; Otsuka Y; Chiba S; Haruyama T; Sato K; Imai Y; Sakurai Y; Ito T; Omata K; Yoshinaga K
Prostaglandins Med; 1980 Jul; 5(1):1-9. PubMed ID: 6996018
[TBL] [Abstract][Full Text] [Related]
9. Interaction of diuretics and non-steroidal anti-inflammatory drugs in man.
Favre L; Glasson P; Riondel A; Vallotton MB
Clin Sci (Lond); 1983 Apr; 64(4):407-15. PubMed ID: 6337769
[TBL] [Abstract][Full Text] [Related]
10. Dissociation of renin--aldosterone and renal prostaglandin E during volume expansion induced by immersion in normal man.
Epstein M; Lifschitz MD; Re R; Haber E
Clin Sci (Lond); 1980 Jul; 59(1):55-62. PubMed ID: 7009025
[TBL] [Abstract][Full Text] [Related]
11. Treatment of low-renin essential hypertension. Comparison of spironolactone and a hydrochlorothiazide-triamterene combination.
Douglas JG; Hollifield JW; Liddle GW
JAMA; 1974 Feb; 227(5):518-21. PubMed ID: 4589187
[No Abstract] [Full Text] [Related]
12. Effects of indomethacin on plasma renin activity, plasma aldosterone concentration, urinary prostaglandin E excretion and blood pressure in patients with essential hypertension.
Yasujima M; Abe K; Chiba S; Sato M; Irokawa N; Imai Y; Saito K; Sakurai Y; Ito T; Ritsu K; Haruyama T; Otsuka Y; Yoshinaga K
Tohoku J Exp Med; 1979 May; 128(1):31-7. PubMed ID: 452004
[No Abstract] [Full Text] [Related]
13. Effect of furosemide on urinary excretion of prostaglandin E in normal volunteers and patients with essential hypertension.
Abe K; Yasujima M; Chiba S; Irokawa N; Ito T; Yoshinaga K; Saito T
Prostaglandins; 1977 Sep; 14(3):513-21. PubMed ID: 905575
[TBL] [Abstract][Full Text] [Related]
14. Effects of 1-Sar-8-Ile-angiotensin II on urinary prostaglandin excretion in patients with essential hypertension.
Yasujima M; Abe K; Otsuka Y; Chiba S; Ritsu K; Irokawa N; Seino M; Sakurai Y; Saito K; Ito T; Yoshinaga K
Tohoku J Exp Med; 1977 Nov; 123(3):271-8. PubMed ID: 601775
[TBL] [Abstract][Full Text] [Related]
15. Effects of orally administered glandular kallikrein on urinary kallikrein and prostaglandin excretion, plasma immunoreactive prostanoids and platelet aggregation in essential hypertension.
Ogawa K; Ito T; Ban M; Mochizuki M; Satake T
Klin Wochenschr; 1985 Apr; 63(7):332-6. PubMed ID: 3889484
[TBL] [Abstract][Full Text] [Related]
16. Triamterene-induced changes in aldosterone and renin values in essential hypertension. Evidence of a role for aldosterone in preventing blood pressure reduction.
Keim HJ; Drayer JI; Thurston H; Laragh JH
Arch Intern Med; 1976 Jun; 136(6):645-8. PubMed ID: 1275620
[TBL] [Abstract][Full Text] [Related]
17. [Influence of spironolactone on urinary prostaglandin E2 and kinin excretions in spontaneously hypertensive rats].
Honda M; Izumi Y; Hatano M
Nihon Naibunpi Gakkai Zasshi; 1988 Jan; 64(1):31-8. PubMed ID: 3288509
[TBL] [Abstract][Full Text] [Related]
18. Influence of spironolactone on urinary prostaglandin E2 and kinin excretion in rats.
Honda M; Hatano M
Prostaglandins Leukot Essent Fatty Acids; 1988 Jan; 31(1):17-21. PubMed ID: 3163804
[TBL] [Abstract][Full Text] [Related]
19. Urinary prostaglandin E2 and kallikrein excretion in glucocorticoid hypertension in rats.
Handa M; Kondo K; Suzuki H; Saruta T
Clin Sci (Lond); 1983 Jul; 65(1):37-42. PubMed ID: 6342908
[TBL] [Abstract][Full Text] [Related]
20. Urinary prostaglandin and sodium metabolism in patients with essential hypertension.
Yasujima N; Abe K; Irokawa N; Chiba S; Sato M; Seino M; Sakurai Y; Saito K; Ito T; Ritsu K; Yoshinaga K
Tohoku J Exp Med; 1978 Mar; 124(3):277-83. PubMed ID: 635902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
